Understanding how reactive astrocytes contribute to aging and neurodegenerative diseases
Function of reactive astrocytes in aging and neurodegenerative disease
This study is looking at how certain brain cells, called reactive astrocytes, change as we age and in diseases like Alzheimer's and Alexander Disease, to find out if understanding these changes can help us find better ways to treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11080548 on NIH RePORTER |
What this research studies
This research investigates the role of reactive astrocytes in the aging process and neurodegenerative diseases, particularly focusing on their behavior in conditions like Alzheimer's and Alexander Disease. The study aims to explore how these cells change in response to injury or inflammation, specifically looking at a protein called GFAP that is crucial for astrocyte function. By using both pharmacological and genetic methods, researchers will examine how certain enzymes affect the behavior of astrocytes in laboratory models and in mice that mimic human disease. This could lead to new insights into how to manage or treat these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's Disease or Alexander Disease, particularly those experiencing significant symptoms.
Not a fit: Patients with neurodegenerative diseases not related to astrocyte dysfunction or those in very advanced stages may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating neurodegenerative diseases, potentially improving outcomes for patients.
How similar studies have performed: Previous research has shown promising results in understanding the role of astrocytes in neurodegeneration, suggesting that this approach could yield valuable insights.
Where this research is happening
Cambridge, United States
- Broad Institute, INC. — Cambridge, United States (Active)
Researchers
- Principal investigator: Battaglia, Rachel — Broad Institute, INC.
- Study coordinator: Battaglia, Rachel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.